Please login to the form below

Not currently logged in


This page shows the latest WHO news and features for those working in and with pharma, biotech and healthcare.

FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics

FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics

FDA Commissioner Scott Gottlieb has taken a swipe at biologics developers who use unwarranted delaying tactics to block the launch of biosimilar competition, saying the approach has robbed US patients of

Latest news

More from news
Approximately 29 fully matching, plus 1,164 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 504 partially matching documents found.

Latest appointments

  • Healthcare Comms appointments Healthcare Comms appointments

    Porterhouse Medical boosts scientific services team. Porterhouse Medical has bolstered its offering with the appointment of Loredana Guglielmi, who joins the medical communications agency as an associate medical writer. ... Guglielmi, who spent the last

  • Industry round up: appointments Industry round up: appointments

    Rodgers, who has gained board experience in both public and private growth companies, has a background in the financial sector as a corporate financier and investment banker. ... Meanwhile, Silence Therapeutics has also bolstered its leadership team with

  • Healthcare comms appointments Healthcare comms appointments

    Knight. O’Regan, who joins Lucid from science communicator group Oxford PharmaGenesis, bolsters the group’s scientific team as she becomes its senior medical writer.

  • Weekly industry appointments Weekly industry appointments

    Appleby, who will succeed CGT Catapult’s first CSO Johan Hyllner, currently serves as chief scientific officer for cell and gene therapy at GlaxoSmithKline’s (GSK) rare diseases unit. ... who has been serving as interim chairman and will revert to a

  • Weekly comms appointments Weekly comms appointments

    However, Winterbottom’s new role will see her work alongside ROAD’s founder and managing director Paul Jarman, who said: “Sarah comes with a huge amount of experience and sector insight.

More from appointments
Approximately 2 fully matching, plus 640 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 792 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....